























































































L’asthme	équin	 est	 caractérisé	 par	 une	 hyperactivité	 bronchique,	 une	 inflammation	
neutrophilique,	 et	 des	 altérations	 structurelles	 des	 voies	 aériennes.	 Chez	 les	 patients	
asthmatiques	 présentant	 une	 inflammation	 neutrophilique,	 les	 corticostéroïdes	 sont	 peu	
efficaces	 pour	 contrôler	 les	 signes	 cliniques.	 L’hypothèse	 de	 cette	 étude	 est	 que	 l’hypoxie	
et/ou	le	stress	oxydatif	dans	le	microenvironnement	des	poumons	peuvent	contribuer	à	une	
insensibilité	 des	 neutrophiles	 aux	 corticostéroïdes	 dans	 l’asthme.	 Les	 chevaux	 sont	 les	
meilleurs	modèles	animaux	naturellement	affectés	par	l’asthme	neutrophilique	et	partagent	
plusieurs	 caractéristiques	 physiopathologiques	 avec	 l’humain.	 La	 viabilité,	 l’apoptose,	
l’expression	génique	d’IL-1b,	TNF-a		et	IL-8	ont	été	mesurées	dans	des	neutrophiles	isolés	à	
partir	de	sang	périphérique	de	chevaux	asthmatiques	sévères	(N=8)	et	de	chevaux	sains	(N=8)	
en	 condition	 de	 culture	 stimulant	 l’hypoxie	 et	 le	 stress	 oxydatif,	 en	 présence	 ou	 non	 de	
corticostéroïdes	 (Dexamethason	 (Dex)).	 L’IL-1b	 et	 le	TNF-a,	mais	pas	 l’IL-8,	ont	été	 régulés	
négativement	en	présence	de	dexaméthasone	dans	des	conditions	de	stress	oxydatif	induites	
par	la	pyocyanin.	Bien	que	l’IL-17	et	le	LPS	aient	stimulé	les	neutrophiles	équins,	l’expression	
génique	 pro-inflammatoire	 n’a	 pas	 diminué	 après	 l’administration	 de	 Dex.	 En	 condition	
d’hypoxie	induite	par	CoCl2,	seulement	l’expression	génique	de	TNF-a	a	considérablement	été	
diminuée	par	 la	Dex,	mais	ceci	a	aussi	été	vrai	en	condition	sans	hypoxie.	En	conclusion,	 le	
stress	 oxydatif,	 mais	 pas	 l’hypoxie,	 entraîne	 une	 insensibilité	 aux	 corticostéroïdes,	 qui	













neutrophils	 to	 corticosteroids.	 Horses	 are	 unique	 animal	 models	 naturally	 affected	 by	
neutrophilic	 asthma	 and	 share	 several	 pathophysiological	 features	 with	 humans.	 Viability,	
apoptosis,	IL-1b,	TNF-a	and	IL-8	gene	expression	were	measured	in	neutrophils	isolated	from	
peripheral	 blood	 of	 severe	 asthmatic	 horses	 (N	 =	 8)	 and	 healthy	 horses	 (N	 =	 8)	 in	 culture	











































































































































































































































Most	 importantly,	 I	 would	 also	 like	 to	 thank	my	 beloved	 and	 supportive	 husband,	












cancers,	 inflammatory	 diseases,	 and	 allergic	 diseases	 such	 as	 asthma.	 The	 neutrophil	 is	 a	
characteristic	cell	of	the	mucous	membranes	(1),	especially	of	the	digestive	tract	and	the	skin,	
but	 it	 is	 also	 found	 in	 the	 thymus,	 the	mammary	 glands	 and	 the	uterus	during	pregnancy.	
Despite	 an	 abundant	 scientific	 literature	 regarding	 neutrophils	 (nearly	 16,000	 articles	 in	
“PubMed”	 to	date),	 the	precise	 role	of	 this	 cell	 in	maintaining	homeostasis	of	 the	 immune	
system	remains	to	be	clarified.	
Severe	 equine	 asthma	 is	 an	 inflammatory	 disease	 that	 affects	 almost	 15%	 of	 the	 horse	
population	 in	 Canada,	 and	 its	 incidence	 seems	 to	 have	 increased	 in	 recent	 decades.	 The	
presence	of	neutrophils	is	a	feature	of	various	chronic	diseases	and	inflammatory	conditions	
such	as	asthma.	Many	studies	have	related	the	presence	of	neutrophils	to	the	severity	of	the	












insensitivity	 of	 pulmonary	 neutrophils	 to	 CS	 in	 asthma.	 Oxidative	 stress	 and	 hypoxia,	 two	
conditions	present	in	the	lungs	of	severe	asthmatic	patients,	have	an	indirect	inhibitory	effect	




















In	 humans	 with	 severe	 asthma,	 there	 is	 persistent	 immune	 activation	 that	 is	
represented	 by	 pulmonary	 leukocyte	 infiltration	 (often	 eosinophils,	 but	 also	 neutrophils).	





                                                
1 Global Strategy for the Diagnosis, Management, and Prevention of chronic Obstructive Pulmonary Disease. Global Initiative 














factors,	or	 that	worsens	when	treatment	dose	 is	decreased	 (5).	 It	 is	 relatively	 refractory	 to	
corticosteroids	 (CS).	 This	 is	 a	 retrospective	 definition,	 dependent	 on	 how	 thoroughly	
contributory	 factors	 are	excluded.	Based	on	data	 from	a	Dutch	population	 survey,	 3.7%	of	
people	over	the	age	of	18	years	have	severe	asthma.	Type	2	inflammation	is	found	in	50%	of	
people	with	severe	asthma.	It	is	characterized	by	cytokines	such	as	interleukin	(IL)-4,	IL-5,	and	
IL-13	 which	 are	 produced	 by	 the	 adaptive	 immune	 system	 in	 recognition	 of	 allergens.	












IL-8	 (a	 strong	 neutrophilic	 chemoattractant	 (7)),	 IL-17	 and	 IFN-g	 are	 the	 principal	
cytokines	 in	 airways	 of	 patients	 with	 neutrophilic	 human	 asthma	 (8).	 Stimulation	 of	 IL-8	
production	 is	 through	 activation	of	 nuclear	 factor	 (NF-kB)	which	 is	 a	 protein	 complex	 that	

























2007,	 ‘Although	neutrophilic	 inflammation	 is	commonly	observed	 in	BALF	from	horses	with	















                                                










included	 the	 terms	 “chronic	 bronchitis”	 and	 “emphysema.”	 The	 GOLD	 Guidelines,	 first	
published	 in	 2002	 (23)	 and	 revised	 in	 20193,	 the	 American	 Thoracic	 Society/European	
Respiratory	Society	 (ATS–ERS)	Guidelines	 issued	 in	2004	(24),	and	the	NICE	Guidelines4	(25)	
reported	in	2004,	deliberately	omitted	these	terms	and	used	only	the	umbrella	term	COPD.	
                                                
3 Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GOLD), 2019; Available from: 
URL: www.ginasthma.org 
4 National Institute for Clinical Excellence (NICE) Guideline available at URL: www.nice.org.uk/CG012niceguideline 
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contrast	 to	 asthma,	 is	 defined	 by	 irreversible	 airflow	 limitations,	 and	 this	 becomes	
progressively	more	severe	as	the	disease	advances.	In	many	(but	not	all)	long-standing	asthma	




Asthma	 and	 COPD	 may	 co-exist	 or	 overlap	 (asthma-COPD	 overlap),	 particularly	 in	


















be	 redefined	 as	 our	 understanding	 of	 them	 deepens,	 and	 as	 new	 effective	 preventive	


















































in	 the	 blood	 and	 lymphatic	 system	 fluids.	 They	 can	 be	 classified	 either	 by	 structure	
(granulocytes	 and	 agranulocytes)	 or	 by	 cell	 lineage	 (myeloid	 cells	 and	 lymphoid	 cells).	 All	
leukocytes	are	derived	from	hematopoietic	stem	cells	(multipotent	cells	in	the	bone	marrow),	



























pro-inflammatory	 mediators,	 chemo-attractive	 and	 immunomodulatory	 cytokines	 (31).	
Consequently,	 they	 are	 involved	 in	 the	 recruitment	 of	 inflammatory	 cells	 to	 the	 site	 of	
inflammation	 and	 they	 will	 contribute	 to	 the	 development	 inflammatory	 disease	 (such	 as	


























Changes	 in	 neutrophil	 morphology	 is	 an	 indicator	 of	 neutrophil	 differentiation	 and	
maturation.	 This	 includes	 staining	 of	 distinct	 granules,	 and	 changes	 in	 nuclear	 shape	 and	
chromatin	patterns	 (Fig.	1.1).	 Immature	 (band)	neutrophils	are	an	 intermediary	step	to	 the	
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be	 subdivided	 into	 segmented	 neutrophils,	 leading	 to	 a	 mature	 granulocyte.	 Mature	
neutrophils	have	a	small	Golgi	apparatus,	mitochondria,	and	ribosomes	or	rough	endoplasmic	
reticulum.	Neutrophils	can	be	found	 in	the	bone	marrow,	spleen,	 liver,	and	 lungs.	The	 lung	
seems	to	be	rich	in	matured	neutrophils.	
	
Fig.	 1.1.	 The	 progression	 of	 neutrophil	 differentiation.	 Changing	 in	 neutrophil	 shape	 and	




Neutrophil	 activation	 may	 cause	 the	 release	 of	 web-like	 filaments	 composed	
of	chromatin	and	serine	proteases	(45)	in	order	to	trap	and	contain	bacteria.	This	may	play	an	
important	 role	 in	 inflammatory	 diseases.	 Brinkmann	 et	 al.	 (2004)	 have,	 for	 the	 first	 time,	
described	 neutrophil	 extra-cellular	 trap	 (NET)	 formation	 induced	 by	 phorbol	 esters	 (PMA),	
Myeloblast Promyelocyte Myelocyte Metamyelocyte Neutrophil
Azurophilic Specific Gelatinase Secretory
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lipopolysaccharides	 (LPS),	 platelet	 activation	 factors	 (PAF),	 and	 interleukin-8	 (IL-8)	 (46).	 As	
NETs	 contain	 neutrophil	 elastase	 (NE),	 myeloperoxidase,	 DNA	 and	 histones,	 they	 can	 also	
potentiate	tissue	damage,	in	part	through	cytotoxic	effects	on	epithelial	and	endothelial	cells	
(47).	These	NETs	can	be	stimulated	by	bacteria,	fungi	and	protozoa.	Because	of	their	physical	









of	 asthma	 development,	 neutrophils	 release	 many	 inflammatory	 mediators	 (48).	 During	
inflammation,	neutrophils	migrate	to	the	airways	of	the	circulatory	system.	In	the	process	of	
migration,	upregulation	of	adhesion	molecules,	 including	CD11b	and	CD18	(Mac-1	integrin),	
occurs.	 Their	 migration	 to	 the	 airways	 depends	 on	 chemo-attractive	 signals,	 and	 the	
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chemotactic	 activity	 of	 neutrophils	 is	 increased	 as	 asthma	 develops.	 This	 phenomenon	 is	
explained	by	an	increase	in	IL-8	and	TNF-a	concentrations	in	the	circulatory	systems	of	patients	
suffering	 from	 asthma,	 both	 being	 chemotactic	 cytokines	 released	 from	 macrophages,	
epithelial	 cells	 and	 neutrophils	 (49-51).	 Furthermore,	 IL-8	 triggers	 degranulation	 of	
granulocytes	 and	 release	 of	myeloperoxidase,	 elastase,	 leukotriene	 B4	 (LTB4)	 and	 reactive	
oxygen	species	(ROS)	(50).	Release	of	ROS	during	the	mechanism	of	oxidative	burst	is	one	of	
the	major	roles	of	neutrophils.	The	granulocytes	may	release	ROS	after	bacterial	stimulation	





previously	reported,	 levels	of	circulating	 low-density	neutrophil-like	granulocytes	 increased,	






recognition	 of	 the	molecules	 of	 foreign	 bodies	 then	 transmitting	 it	 to	 the	 defense	 cells	 to	
activate	effectors	to	remove	these	foreign	bodies.	The	immune	response	is	divided	into	innate	









fMLP,	 LTB4	 and	 hydrogen	 peroxide	 (H2O2)	 (56).	 In	 condition	 of	 inflammation,	 neutrophils	
capture	and	destroy	 foreign	particles	 through	phagocytosis.	After	 they	are	encapsulated	 in	
phagosomes,	 the	 cells	 kill	 the	 pathogens	 using	 NADPH	 oxygenase-dependent	mechanisms	
(reactive	 oxygen	 species)	 or	 antibacterial	 proteins	 (cathepsins,	 defensins,	 lactoferrin	 and	













Cells	 of	 the	 immune	 system	 secrete	 a	 variety	 of	 glycoproteins	 in	 response	 to	 the	
inductive	 intercellular	 signals	 that	 regulate	 immune	 responses.	 The	 generic	 term	 for	 these	




to	 the	 development	 of	 cellular	 and	 humoral	 immune	 responses,	 the	 regulation	 of	
hematopoiesis,	the	control	of	cellular	proliferation	and	differentiation,	wound	healing,	and	the	
synthesis	 of	 a	 variety	 of	 receptors	 or	 other	 proteins.	 Cytokines	 are	 secreted	 mainly	 by	
lymphocytes	and	macrophages,	but	also	by	granulocytes,	endothelial	cells,	fibroblasts,	and	by	
most	structural	cells.	Human	endothelial	cells	are	capable	of	expressing	a	broad	spectrum	of	







cells	at	the	site	of	 inflammation,	 in	both	autocrine	and	paracrine	manners	(63).	 It	has	been	





















Asthma	 is	 the	 consequence	 of	 the	 interplay	 of	 genetics	 and	 environmental	 factors.	
Therefore,	 there	 is	a	possibility	 that	adequate	control	of	symptoms	cannot	be	achieved	for	
some	 patients	 (65),	 and	 inter-individual	 differences	 in	 response	 to	 asthma	 treatment	 and	





Since	 cigarette	 smoking	 would	 be	 an	 environmental	 factor,	 that	 may	 influence	 asthma	
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treatments	by	 impairing	 the	 response	 to	CS	 (both	 inhaled	and	oral)	 (69),	and	perpetuating	
symptoms	despite	treatment	(70).	
The	 treatment	 of	 inflammatory	 diseases	 of	 the	 airways	 differs,	 based	 on	 different	
stages	or	diseases.	For	instance,	neutrophilic	asthma	and	COPD	share	some	common	features	
in	 the	 lower	 airways,	 including	 inflammation	 (neutrophilia	 with	 increased	 IL-8,	 Matrix	
metalloproteinase	9	(MMP-9),	and	neutrophil	elastase)	(71).	Thus,	the	common	principles	of	
therapeutic	approaches	are	the	same.	Treatments	are	used	to	control	exacerbation,	and	to	









Drugs	 used	 for	 asthma	 treatment	 are	 classified	 into	 two	main	 groups.	 The	 first	 are	
controller	medications,	which	are	used	for	symptom	control,	reducing	airway	inflammation,	
and	preventing	complications	such	as	lung	function	deterioration	or	symptom	exacerbations.	




























GRβ	 regulates	 gene	 transcription	of	 non-GRα	 target	 genes,	 in	 a	GRα-	 and	GC-independent	
manner	(83).	Table	1.4	demonstrates	the	up-regulatory	and	down-regulatory	effects	of	CS	on	
gene	expression.	
All	 splicing	 isoforms	 show	 diminished	 activity	 compared	 to	 GRa	 (84-86).	 Besides	
splicing,	GR	mRNA	is	further	regulated	post-transcriptionally.	The	GR	protein	variants	all	have	
a	similar	GC	and	glucocorticoid	responsive	element	(GRE)	binding	affinity,	but	they	differ	in	the	



















In	 the	 inactivated	 state,	 GR	 exists	 predominantly	within	 the	 cytoplasm,	 bound	 to	 a	
chaperone	 complex	 which	 includes	 heat	 shock	 proteins	 (HSPs)	 90,	 70,	 and	 50,	 and	
immunophilins.	HSP90	regulates	ligand	binding	and	retains	GR	in	the	cytoplasm.	Upon	binding	
ligands	(GC),	GR	undergoes	conformational	changes	that	release	it	from	chaperone	proteins,	
inducing	 rapid	 transit	 into	 the	 nucleus	 (88).	 Although	 uninduced	 GR	 is	 predominantly	
cytoplasmic	 and	 activated	GR	 is	 predominantly	 nuclear,	 both	 activated	 and	 inactivated	GR	
forms	have	been	shown	to	shuttle	between	the	nucleus	and	cytoplasm	(82).	
Once	in	the	nucleus,	GR	binding	to	GRE	increases	transcription	of	target	genes	via	cis-
activation	 (89).	 However,	 binding	 to	 negative	 GRE	 sites,	 through	 cis-repression	 reduces	
transcription	of	certain	genes	(83,	90).	In	addition	to	interaction	with	DNA	directly,	activated	





like	 other	 steroid-derived	 lipophilic	 ligands,	 diffuses	 through	 the	 cell	 membrane	 into	 the	
cytoplasm,	where	it	binds	and	activates	its	receptor	(Fig.	1.4)	(91).	After	GR	is	transported	to	









Fig.	 1.4.	 Nucleocytoplasmic	 shuttling	 of	 the	 glucocorticoid	 receptor.	 Upon	 binding	 to	 the	
ligand,	 the	activated	GRα	dissociates	 from	HSPs	and	 translocate	 into	 the	nucleus,	where	 it	





















• 2-adrenergic	receptors	 • Mediator	receptors	(Neurokinin	(NK	1),	bradykinin	(B2)-
receptors)	




NF-kB	 remains	 in	 an	 inactive	 state	 by	 being	 bound	 to	 IκB	 alpha.	 In	 response	 to	
stimulation,	these	two	molecules	dissociate,	the	IkB	alpha	is	rapidly	degraded,	and	the	active	
NF-kB	is	free	to	act.	Glucocorticoids	block	all	NF-kB-mediated	processes,	 including	cytokine	
synthesis.	 They	 also	 have	 effects	 on	 leukocyte	 circulation,	 blocking	 the	 emigration	 of	
leukocytes	from	the	capillaries	by	inhibiting	vascular	permeability	and	vasodilation.	
Glucocorticoids	modulate	the	activities	of	inflammatory	mediators	and	modify	protein,	


















Fig.	 1.6.	 Inhaled	 corticosteroids	 inhibit	 the	 transcription	 of	 several	 inflammatory	 genes	 in	
airway	 epithelial	 cells.	 NF-kB:	 nuclear	 factor	 κB;	 AP-1:	 activator	 protein-1;	 GM-CSF:	
granulocyte-macrophage	colony-stimulating	 factor;	 IL-1:	 interleukin-1;	 iNOS:	 inducible	nitric	












as	 neutrophils,	 monocytes	 and	 eosinophils,	 but	 neutrophil	 migration	 is	 enhanced	 in	 the	




COPD	 show	 some	 degree	 of	 CS	 resistance.	 Asthmatics	 who	 smoke	 are	 also	 relatively	 CS-
resistant	and	require	increasing	doses	of	CS	for	asthma	control	(96).	
Resistance	 to	CS	 treatment,	exacerbations	of	 the	disease	and	occupational	 forms	of	
asthma	could	be	all	associated	with	increased	neutrophil	counts	in	the	peripheral	blood	and	
BALF	(97).	Neutrophilic	mediators	cause	remodeling	of	bronchial	walls,	which	 leads	to	 local	
fibrotic	 changes	 (48).	 A	 similar	 mechanism	 occurs	 in	 certain	 autoimmune	 conditions	 (98).	
Remodeling	 of	 large	 central	 bronchi	 could	 be	 at	 least	 partly	 responsible	 for	 resistance	 to	
therapy	 with	 bronchodilators.	 CS	 improve	 clinical	 signs	 and	 airway	 obstruction	 in	 severe	
asthmatic	horses,	while	 airway	neutrophilia	persists	 (20,	 99),	 and	 it	 has	 a	 similar	 effect	on	















the	 transcription	 of	 pro-inflammatory	 genes	 by	 blocking	 NF-kB	 pathways	 as	 well	 as	 other	





also	 influences	 neutrophil	 function.	 Neutrophils	 alter	 the	 mRNA	 expression	 profiles	 of	
epithelial	cells	as	they	migrate	across	the	epithelium,	which	consequently	upregulates	genes	

















Oxidative	 stress	 has	 been	 defined	 as	 a	 disturbance	 in	 the	 balance	 between	 the	




the	 former,	 leading	 to	potential	damage.”	Balanced	 formation	of	ROS	and	 induction	of	 the	
antioxidant	network	is	essential	for	biological	processes	and	cell	regulations	(107).	However,	







Neutrophils,	 eosinophils,	 alveolar	 macrophages,	 bronchial	 epithelial	 cells,	 and	
endothelial	cells	are	the	first	line	of	defense	in	case	of	inflammation.	They	are	the	main	cellular	
sources	of	ROS	in	the	lung	(109-111).	
Production	of	ROS	was	 first	 reported	 in	1968	by	Paul	and	Sbarra,	who	showed	 that	












molecules	 needed	 for	 this	 chemical	 reaction	 derive	 from	 extracellular	 sources	 of	 oxygen	






mitochondrial	 (NOX1	 complex	 or	 RIPK1-dependent)	 sources	 (114).	 ROS	 production	 during	
oxidative	 bursts	 is	 non-mitochondrial	 and	 results	 from	 the	 regulated	 activation	 of	 NOX	
proteins.	 In	 contrast,	 non-phagocytic	 cells	 and	 phagocytes	 such	 as	 granulocytes,	 such	 as	
neutrophils,	monocytes	and	macrophages	generate	ROS	by	the	use	of	an	analogous	NADPH	






peroxide	 (H2O2)	 affect	 cells	 differently,	 react	 with	 diverse	 antioxidant	 enzymes,	 and	 have	




ROS	 have	 a	 close	 relationship	with	 the	 oxygen	 content	 of	 cells	 and	with	 numerous	
biological	processes.	It	is	clear	that	ROS	mediate	inflammatory	damage	and	control	apoptosis	
and	cell	proliferation	(119,	120).	ROS	generation	is	itself	 induced	by	cytokines,	and	it	can	in	
turn	 stimulate	 pro-inflammatory	 cytokine	 production	 by	 activating	NF-kB.	 Previous	 studies	
have	 indicated	 that	 TNF-a,	 ROS,	 and	 NF-kB	 are	 inextricably	 tied	 together	 in	 immunity,	










cells	 under	 inflammatory	 conditions.	 RNS	 are	 signaling	 molecules	 with	 antiviral	 and	
antibacterial	 properties,	 and	 can	 inhibit	 DNA	 synthesis,	 cell	 proliferation	 and	 collagen	
production	(124).		
NO	 is	 generated	within	 the	human	 lung	and	 is	measurable	 in	exhaled	breath	 (125).	
Interestingly,	whereas	NO	 levels	 are	 decreased	 in	 nasal	 polyposis	 (124),	 asthmatics	 exhibit	









and	 consequently	 lipid	 and	 DNA	 damage.	 The	 neutrophils	 in	 patient	 with	 chronic	
granulomatous	disease	(CGD)	phagocytose	normally,	but	the	respiratory	burst	is	absent	and	
NADPH	 oxidase	 activity	 (and	 radical	 production)	 is	 undetectable.	 This	 indicates	 that	 the	
oxidase	 has	 an	 important	 mitochondrial	 function.	 Cytokines	 mediate	 the	 ROS	 production	
pathway	by	participating	in	signal	transduction	pathways	(involving	kinases	and/or	phosphate	











during	phagocytosis	 to	degrade	 internalized	particles	and	bacteria.	 It	was	 thought	 to	result	
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different	 between	 transcribing	 and	 non-transcribing	 nuclear	 DNA,	 as	 well	 as	 between	
mitochrondrial	DNA	and	different	types	of	RNA.	Increased	ROS	levels	contribute	to	oxidative	
DNA	damage	and	may	lead	to	mutations.	DNA	damage	can	be	detected	and	repaired	by	several	
mechanisms	 or,	when	 not	 repaired,	 can	 induce	 apoptosis	 to	 avoid	 the	 passing	 on	 of	 DNA	
mutations	 to	 progeny	 cells.	 This	 apoptotic	 pathway	 is	 activated	 by	 NF-kB.	 NF-kB	 is	 also	












Recent	 studies	 in	 horses	 have	 shown	 nuclear	 and	 mitochondrial	 DNA	 damage	 in	
response	 to	 elevated	 levels	 of	 ROS	 (135).	 Furthermore,	 low	 ROS	 levels	 act	 as	 second	




Lipids,	 proteins,	 and	 carbohydrates	 are	 further	 examples	 of	 molecules	 that	 can	 be	
modified	by	excessive	ROS	in	vivo.	In	asthmatic	horses,	8-epi-PGF2	alpha,	a	marker	of	oxidative	
stress,	 is	 increased	 in	 the	 lungs	 (137).	ROS	can	be	measured	directly	 (e.g.,	by	electron	spin	











exercise	 induces	 pulmonary	 oxidative	 stress	 in	 both	 equine	 and	 human	 athletes	 and	 can	
increase	pulmonary	oxidants/antioxidant	disequilibrium	(139).	
Both	 eosinophils	 and	 neutrophils	 participate	 in	 the	 innate	 immune	 response,	 and	
produce	ROS	and	RNS	in	response	to	different	stimuli	(140).	The	severity	of	oxidative	stress	
appears	 to	 be	mild	 during	 the	 early	 stages	 of	 an	 inflammatory	 response	 in	 severe	 equine	
asthma,	despite	a	high	number	of	neutrophils	 in	 the	 lung	 (141).	The	effects	of	neutrophilic	
airway	inflammation	on	the	pulmonary	antioxidant	status	and	on	the	induction	of	oxidative	
stress	 are	 dependent	 upon	 the	 duration	 of	 inflammation	 and	 the	 magnitude	 of	 the	
inflammatory	 response,	 suggesting	 that	 inflammatory	 bursts	 contribute	 to	 higher	 ROS	
production	(139,	142,	143).		
Increased	 levels	 of	 biomarkers	 for	 oxidative	 stress,	 such	 as	 higher	 endogenous	
oxidative	DNA	damage,	have	been	determined	in	peripheral	blood	mononuclear	cells	derived	
from	severe	asthmatic	horses	in	clinical	remission.	Moreover,	increases	in	IL-1b,	IL-6,	TNF-a,	
IL-8,	 oxidized	 glutathione	 (GSSG),	 8-isoprostane	 and	 MPO,	 as	 well	 as	 decreased	 levels	 of	
ascorbic	acid	in	pulmonary	epithelial	lining	fluid	(PELF),	and	increased	levels	of	GSH	and	GSSG	
in	erythrocytes,	are	other	 indicators	of	oxidative	stress	 in	asthmatic	horses	(139,	142,	143).	














oxygen	 homeostasis.	 In	 1995,	 a	 hypoxia-responsive	 transcription	 factor	was	 described	 and		
termed	 hypoxia-inducible	 factor-1	 (HIF-1)	was	 introduced.	 The	 inception	 of	 HIF-1	 signaling	
depends	on	the	absence	of	a	molecule	rather	than	the	presence	of	one.	Since	that	discovery,	






subunit	 is	 highly	 susceptible	 to	 oxygen	 and	 becomes	 immediately	 hydroxylated	 at	 specific	
prolyl	 and	 asparaginyl	 residues	 in	 the	 presence	 of	 oxygen,	 which	 keeps	 the	 subunit	 in	 an	
inactive	 state	 (147-149).	 Under	 low	 oxygen	 concentrations	 (less	 than	 6%),	 hydroxylation	













and	 differentiation.	 This	 occurs	 under	 man	 physiological	 conditions,	 such	 as	 embryonic	
development,	 cell	 differentiation,	 and	 wound	 healing.	 Hypoxia	 may	 also	 occurs	 as	 the	
consequences	 of	 several	 pathologies	 including	 neoplasia,	 interstitial	 lung	 diseases,	 COPD,	
arteriosclerosis	 and	 asthma	 (154-156).	 HIF-1α,	 when	 activated,	 regulates	 mitochondrial	






aspects	 of	 neutrophil	 biology,	 and	 these	 cells	 display	 distinct	 properties	when	 exposed	 to	





oxygen,	 	 generating	 hypochlorous	 acid	 (HClO)	 and	 ROS	 which	 are	 then	 used	 to	 lyse	 the	
microbes	 (159).	 This	 process	 increases	 consumption	 of	 molecular	 oxygen	 (160)	 and	 could	
contribute	to	a	hypoxic	condition.	Under	hypoxia,	neutrophil	activities	will	change.	They	could	
alter	tissue	microenvironment	by	depleting	the	local	oxygen	molecules.	Neutrophils	could	alter	
the	mRNA	expression	of	 certain	pro-inflammatory	cytokines	 like	TNF-a	 and	 IL-1b	 in	airway	
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neutrophilic	 asthma	 and	 share	 several	 pathophysiological	 features	 with	 human.	 Blood	
neutrophils	 isolated	 from	 severe	 asthmatic	 horses	 (N=8)	 and	 healthy	 horses	 (N-8)	 were	
incubated	under	different	cell	culture	in	the	presence	of	dexamethasone.	Neutrophil	function	




stress	 condition.	 Although,	 IL-17	 and	 LPS	 stimulated	 equine	 neutrophils,	 increased	 pro-
inflammatory	 gene	 expression	 was	 unaffected	 after	 dexamethasone	 administration.	 In	
hypoxemia	mimicked	by	cobalt	chloride	(CoCl2),	dexamethasone	significantly	down	regulated	
gene	 expression.	 Greater	 IL-8	 production	 in	 neutrophils	 from	 severe	 asthmatic	 horses	
compared	with	healthy	subjects	were	seen,	though	neutrophils	from	both	groups	shown	the	
















the	most	effective	drugs	 for	 the	treatment	of	asthma,	some	patients,	especially	 those	with	
neutrophilic	 inflammation,	are	 insensitive	 to	 their	action.	Furthermore,	 in	both	human	and	
equine	asthma,	 the	neutrophilic	 inflammation	persists	 in	 the	airways	of	 individuals	 treated	
with	these	drugs.	Our	laboratory	has	previously	demonstrated	that	human	and	equine	blood	
neutrophils	from	healthy	individuals	are	as	responsive	as	other	leukocytes	to	CS	in	vitro.	These	
results	 suggest	 that	 the	 lung	 microenvironment	 is	 responsible	 for	 the	 insensitivity	 of	
pulmonary	neutrophils	to	CS	in	asthma.	






reactive	 oxygen	 species	 (ROS)	 (169).	 Unbalance	 between	 ROS	 production	 and	 antioxidant	
defenses	 leads	 to	 oxidative	 stress,	 and	 consequently	 to	 tissue	 injury	 and	 damage	 to	 cell	








the	activated	 inflammatory	genes	 (101).	These	results	are	 likely	 to	 reflect	 the	resistance	of	
pulmonary	 inflammation	 to	CS	 in	 severe	 asthmatic	 patients	 as	 a	 result	 of	 the	 reduction	 in	
HDAC2	(171,	172).	HDAC2	is	an	enzyme	that	prevents	the	transcription	of	pro-inflammatory	
genes	by	blocking	nuclear	factor-kB	(NF-kB)	pathways	and	inhibiting	the	transcription	of	other	
factors,	 such	as	 tumor	necrosis	 factor-α	 (TNF-α),	 IL-8,	and	granulocyte-macrophage	colony-








Upon	 activation,	 blood	 neutrophils	 synthesize	 proteins,	 including	 a	 variety	 of	
chemokines,	 that	are	 implicated	 in	 the	recruitment	of	distinct	 leukocytes.	They	can	release	





capacity	 to	 regulate	 their	 cytokine	 and	 chemokine	 production	 in	 response	 to	 stimuli	 and	
inflammation	 (62).	 Cytokine	 production	 (such	 as.	 IL-8,	 IL-1b	 ,	 and	 TNF-a)	will	 increase	 the	
degree	of	inflammation,	as	is	the	case	in	severely	asthmatic	humans	and	horses	(62,	175,	176).	
Studies	 have	 described	 pro-inflammatory	 gene	 regulation	 in	 neutrophil	 activation	 and	
recruitment	 into	 the	 airway	 in	 human	 asthma	 (177,	 178),	 and	 insensitivity	 of	 human	
neutrophils	to	CS	(179-182).	
Neutrophils	 could	 be	 predisposed	 to	 cytokine	 production	 associated	with	 Th2	 type	
receptors,	 in	 order	 to	 respond	 to	 inflammation	 (183-185).	 This	 activation	 is	 thought	 to	



























30	 minutes	 of	 sedimentation	 at	 room	 temperature	 using	 a	 density	 gradient	 method	 of	
separation	Ficoll-PaqueTM	Premium	1084	(Fisher	Scientific,	Ottawa,	ON,	CA).	The	leukocyte	
polymorphonuclear-depleted	 and	 polymorphonuclear-rich	 cell	 layers	were	 both	 harvested,	
and	the	remaining	erythrocytes	were	lysed	by	hypotonic	treatment	using	ultra-pure	water	(Life	
technologies,	 Burlington,	 ON,	 CA).	 Cells	 were	 washed	 and	 suspended	 in	 a	 buffer	 solution	
containing	PBS	1X,	EDTA	0.5	mM	(Life	technologies,	Burlington,	ON,	CA),	and	BSA	0.2%	(Sigma-
Aldrich,	 St	 Louis,	MO,	 USA).	 Purity	 was	 evaluated	 in	 cytospin	 stained	 slide	 for	 differential	
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Freshly	 isolated	 peripheral	 blood	 neutrophils	 were	 suspended	 at	 5	 ×	 106/ml	 and	
cultured	 in	 5	 ml	 tubes	 (Corning	 Incorporated,	 Corning,	 NY,	 USA)	 in	 RPMI	 medium	
supplemented	with	L-glutamine	200	mM,	100	U/ml	penicillin,	100	U/ml	streptomycin,	and	10%	
of	low-endotoxin,	heat-inactivated	fetal	bovine	serum	(Life	Technologies,	Burlington,	ON,	CA).	











































Equal	 amounts	 of	 protein	 (30	 μg	 per	 lane)	 were	 separated	 based	 on	 their	 size	 by	 SDS—
PAGE	12%	Mini-PROTEAN®	TGX™	Precast	Gels	 (Bio-Rad	 Laboratories,	Mississauga,	ON,	 CA)	
then	they	were	blotted	onto	polyvinylidene	difluoride	(PVDF)	membranes	(Bio-Rad,	Hercules,	
USA).	We	detected	HIF-1	α	protein	using	a	Rabbit	Polyclonal	antibody	 (20960-1-AP,	HIF1	α	








Generation	 of	 extracellular	 superoxide	was	 assessed	 to	measure	 ROS	 production	 in	
cultured	neutrophils.	We	used	My	Qubit	Amplex™	Red	Peroxide	Assay	 to	detect	 hydrogen	






























H2O2	 production	 level	 (as	 ROS)	 in	 equine	 blood	 neutrophils	 primed	 by	 IL-17	 and/or	 LPS,	 and	




















to	 unstimulated	 neutrophils,	 IL-8	 (P<0.0001)	 and	 IL-1β	 (P<0.0001)	 mRNA	 expression	 was	











The	mRNA	 expression	 of	 IL-8,	 IL-1β,	 and	 TNF-α	 (Fig.	 2.5)	were	 unaffected	 by	 hypoxia	
conditions	 induced	 by	 CoCl2.	 Although,	 Dex	 downregulated	 the	 expression	 of	 IL-1β,	 this	
improvement	was	not	significantly	different	between	healthy	and	asthmatic	horses	(P=0.15,	and	
P=0.014	 (which	was	not	 significant	after	adjustement,	 respectively)	 (Fig.	2.5	B).	Similarly,	Dex	












present	 in	 the	 lung	microenvironment	 contribute	 to	 the	CS	 insensitivity	of	neutrophils	 in	 the	










consequence	 of	 physiological	 changes.	 Responding	 to	 this	 pathologic	 stress	 in	 the	 lung	
microenvironment,	 neutrophils	 can	modulate	 the	 gene	 expression	 of	 the	 epithelium	 as	 they	









contributing	 to	 CS	 insensitivity.	 Indeed,	 CS	 insensibility	 is	 gene-dependent	 as	 shown	 by	 the	
preferentially	regulation	of	IL-8	in	response	to	the	oxidative	stress.	Moreover,	similar	effects	on	
neutrophilic	 activity	were	observed	 in	both	healthy	and	asthmatic	horses,	 indicating	 that	 the	
response	of	these	 leukocytes	 is	not	 influenced	by	the	asthmatic	status.	Taken	together,	these	
findings	indicate	a	possible	contribution	of	IL-8	to	the	persistence	of	neutrophils	in	the	airways	
of	 CS-treated	 samples	 as	 a	 key	 chemokine	 regulating	 neutrophil	 recruitment	 in	 the	 inflamed	
airways.	




IL-1β	 and	 TNF-α,	 IL-8	 appears	 to	 be	 the	 core	 factor	 of	 CS	 insensitivity	 in	 neutrophils,	 as	 its	
expression	 was	 not	 attenuated	 by	 Dex	 administration.	 Human	 studies	 revealed	 that	 PCN	
enhances	neutrophil	extracellular	 trap	 (NET)	 formation	 in	neutrophils	 (196).	As	our	and	other	
group	 previously	 reported,	 Netosis	 is	 increased	 in	 the	 lungs	 of	 asthmatic	 horses	 (187,	 197).	
Considering	this,	these	findings	suggest	that	Netosis	is	associated	with	CS	insensitivity	in	severe	
neutrophilic	asthma	(198).	Therefore,	one	possible	explanation	for	this	insensitivity	to	CS	could	
be	 the	 effect	 of	 PCN	 on	 Netosis,	 which	 would	 be	 in	 agreement	 with	 human	 studies	 which	
reported	that	low	concentration	of	PCN	can	rapidly	lead	to	NET	formation	(196).	According	to	









statistically	 significant.	 Previous	 studies	 revealed	 that	 hypoxia	 selectively	 inhibits	 respiratory	
burst	activity	of	human	neutrophils.	 In	 these	studies,	 IL-8	gene	expression	was	unaffected	by	











these	 cytokines,	which	 are	 hallmarks	 of	 acute	 inflammatory	 processes,	 in	 horse	 (193)	 and	 in	
human	cells	(202-204).	Our	results	are	in	concordance	with	published	studies	which	report	that	
cytokines	and	chemokines	have	distinct	kinetic	characteristics	 in	 response	 to	different	stimuli	





































































































































(n	 =	 8)	 were	 incubated	 with	 pyocyanin.	 After	 3.5	 h,	 pro-inflammatory	 gene	 expression	 was	























































































































































































































































































































































































suffering	 from	severe	asthma,	 the	presence	of	neutrophils	may	be	associated	with	 increased	
severity	of	disease	(188,	189).	Because	of	limited	supply	of	oxygen	to	the	lungs,	severe	asthma	
patients	 suffer	 from	 hypoxia.	 Moreover,	 as	 neutrophils	 are	 potential	 promoters	 of	 ROS	
production,	 and	 they	 are	 considered	 as	 one	 of	 the	major	 sources	 of	 oxidants	 in	 lungs	 (190),	





Our	 result	 confirmed	 that	 oxidative	 stress	 could	 participate	 to	 the	 CS	 insensibility	 of	
equine	blood	neutrophils.	In	order	to	mimic	oxidative	stress	conditions,	we	used	pyocyanin	(PCN)	
in	 our	 culture.	 PCN-mediated	 induction	 of	 oxidative	 stress	 is	 due	 to	 its	 ability	 to	 increase	
intracellular	ROS	levels,	especially	of	hydrogen	peroxide	(H2O2)	(216).	PCN,	secreted	by	the	gram-
negative	 bacterium	 Pseudomonas	 aeruginosa,	 contributes	 to	 the	 inflammatory	 response	 in	
patients	with	cystic	fibrosis	(217,	218).	PCN	has	been	used	as	an	inducer	of	oxidative	stress	in	
biological	 studies	 (219-221).	 Similarly,	 in	 our	 model,	 PCN	 led	 to	 increased	 levels	 of	 H2O2	




223).	Our	 study	 is	 the	 first	 to	demonstrate	 that	PCN	 stimulates	 an	 inflammatory	 response	 in	
asthma.	 PCN	 participates	 in	 neutrophilic	 inflammation	 by	 increasing	 IL-8	 (a	 neutrophil	
chemoattractant)	gene	expression	in	the	human	airways	(194,	195).	Similarly,	herein	we	found	
that	PCN-induced	oxidative	stress	increases	the	mRNA	expression	of	IL-8,	but	not	of	IL-1b	and	
TNF-a	 in	 neutrophils	 derived	 from	 healthy	 and	 asthmatic	 horses.	 IL-8	 upregulation	 was	
unaffected	after	dexamethasone	(Dex)	treatment	in	PCN-induced	oxidative	stress	conditions	in	
vitro.	 These	 results	 contrast	 with	 previous	 studies	 which	 demonstrated	 IL-8	 suppression	 in	
bronchial	epithelial	cells	after	CS	administration	(224-226).	In	the	study	of	Pan	and	coworkers,	
Dex	 was	 the	most	 effective	 CS	 for	 attenuating	 the	 IL-8	 release	 in	 cultured	 human	 bronchial	





significant	 improvement	 in	 clinical	 signs	 and	 airway	 obstruction	 are	 seen	 (12,	 227,	 228).	



























expression	 was	 not	 triggered.	 Previous	 studies	 revealed	 that	 hypoxia	 selectively	 inhibits	
respiratory	burst	activity	of	human	neutrophils	 (231).	 In	their	study,	 IL-8	gene	expression	was	





(165).	 This	 suggest	 that	 energy	 stores	 are	 more	 intimately	 related	 to	 the	 levels	 of	 the	
transcription	factor	in	mononuclear	cells	compared	to	neutrophils.		
Equine	blood	neutrophils	may	need	more	exposure	time	to	the	condition	of	hypoxia	in	
order	 to	 show	 significantly	 higher	 level	 of	 HIF-1α	 in	 comparison	 to	 untreated	 neutrophils.	
Although	 in	 vitro	 detection	 of	many	 inflammatory	mediators	was	 not	 significantly	 altered	 by	
either	hypoxia	or	LPS	stimulation	in	neutrophils	(231),	others	have	shown	an	increase	in	IL-8	gene	
and	protein	expression	in	CoCl2-induced	hypoxia	conditions	in	human	endothelial	cells	(232).	In	
contrast	 to	our	results,	 it	has	been	reported	that	CoCl2	 increases	the	release	of	 inflammatory	
cytokines	 through	TLR4	pathways	 in	 immune	cells	 like	monocytes	and	neutrophils	 (233,	234).	
Also,	it	has	been	demonstrated	that	CoCl2	triggers	the	release	of	neutrophil	extracellular	traps	






Studies	 from	 our	 group	 have	 suggested	 that	 IL-17	 could	 contribute	 to	 neutrophilic	
inflammation	by	upregulating	IL-8	gene	expression	(61).	Additionally,	Murcia	et	al.	demonstrated	






activate	 neutrophil	 recruitment,	 and	 following	 this,	 increase	 the	 levels	 of	 pro-inflammatory	




neutrophils	 with	 IL-17	 would	 enhance	 LPS-induced	 ROS	 production.	 This	 assumption	 was	
supported	by	a	study	showing	that	IL-17	induces	the	NAD(P)H-oxidase	dependent	generation	of	
superoxide	 and	 hydrogen	 peroxide,	 which	 is	 involved	 in	 the	 release	 of	 pro-inflammatory	




However,	 we	 showed	 that	 neutrophil	 stimulation	with	 IL-17+LPS	 increases	 the	mRNA	
expression	 of	 the	 pro-inflammatory	 genes	 IL-8,	 IL-1b	 and	 TNF-a.	 In	 agreement	 with	 these	
findings,	 IL-17	 alone	 increased	 production	 of	 these	 cytokines,	 which	 are	 hallmarks	 of	 acute	
inflammatory	processes,	in	horse	(193)	and	in	human	cells	(202-204).	Our	results	demonstrate	
that,	 the	mRNA	expression	of	 IL-1b	 and	 TNF-a	 similar	 to	 that	 of	 IL-8	 in	 IL-17+LPS	 stimulated	
neutrophils,	were	unaffected	after	Dex	treatement.	LPS	induced	the	release	of	IL-8,	TNF-α,	IL-6,	
IL-10,	 and	 MIP-1β,	 but	 this	 was	 not	 modified	 by	 hypoxia	 (231).	 Therefore,	 neutrophils	 had	
selective	 activation.	 Our	 results	 are	 in	 agreement	 with	 published	 studies	 which	 report	 that	
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cytokines	and	chemokines	have	distinct	kinetic	characteristics	 in	 response	 to	different	stimuli	



































factor	 protein,	which	has	 important	 functional	 effects	 on	mature	 cells,	 including	 neutrophils,	
monocytes,	and	eosinophils.	It	has	been	reported	that	GM-CSFRβ	expression	was	also	lower	in	




















for	 fluorescence	 detection	 in	 FL-3	 and	 FL-4	 channels.	 APC	 Annexin	 V-negative	 and	 7-AAD-
negative	cells	were	considered	viable.	







1a	 expression	 at	 the	 protein	 level	 in	 human	 neutrophils,	 without	 seeing	 any	 significance	






mediator	 of	 inflammatory	 conditions,	 although	 corticosteroid	 treatments	 could	 reduce	 the	
inhibitory	effect	of	the	medication	by	TNF-α	production	(246).	






1. Parkos CA. Neutrophil-Epithelial Interactions: A Double-Edged Sword. The American 
journal of pathology. 2016;186(6):1404-16. 
2. Hirsch G, Lavoie-Lamoureux A, Beauchamp G, Lavoie JP. Neutrophils are not less 
sensitive than other blood leukocytes to the genomic effects of glucocorticoids. PLoS One. 
2012;7(9):e44606. 
3. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An 
official American Thoracic Society/European Respiratory Society statement: asthma control 
and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. 
American journal of respiratory and critical care medicine. 2009;180(1):59-99. 
4. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al. A new 
perspective on concepts of asthma severity and control. The European respiratory journal. 
2008;32(3):545-54. 
5. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International 
ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European 
Respiratory Journal. 2014;43(2):343-73. 
6. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and 
possible mechanisms. Thorax. 2002;57(7):643-8. 
7. Baines KJ, Simpson JL, Wood LG, Scott RJ, Gibson PG. Systemic upregulation of 
neutrophil α-defensins and serine proteases in neutrophilic asthma. Thorax. 2011;66(11):942-7. 
8. Poon AH, Eidelman DH, Martin JG, Laprise C, Hamid Q. Pathogenesis of severe 
asthma. Clinical & Experimental Allergy. 2012;42(5):625-37. 
9. Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, et al. 
Airway cytokine expression measured by means of protein array in exhaled breath condensate: 
correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol. 
2006;118(1):84-90. 
10. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent 
asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 
2001;119(5):1329-36. 
11. Shute JK, Vrugt B, Lindley IJ, Holgate ST, Bron A, Aalbers R, et al. Free and complexed 
interleukin-8 in blood and bronchial mucosa in asthma. American journal of respiratory and 
critical care medicine. 1997;155(6):1877-83. 
12. Leclere M, Lavoie-Lamoureux A, Lavoie J-P. Heaves, an asthma-like disease of horses. 
Respirology. 2011;16(7):1027-46. 
13. Lavoie J-P. Is the time primed for equine asthma? Equine Veterinary Education. 
2015;27(5):225-6. 
14. Couëtil LL, Cardwell JM, Gerber V, Lavoie J-P, Léguillette R, Richard EA. 
Inflammatory Airway Disease of Horses—Revised Consensus Statement. Journal of Veterinary 
Internal Medicine. 2016;30(2):503-15. 
15. Seahorn TL, Beadle RE. Summer pasture-associated obstructive pulmonary disease in 
horses: 21 cases (1983-1991). Journal of the American Veterinary Medical Association. 
1993;202(5):779-82. 
16. Couetil LL, Hoffman AM, Hodgson J, Buechner-Maxwell V, Viel L, Wood JL, et al. 
Inflammatory airway disease of horses. J Vet Intern Med. 2007;21(2):356-61. 
 
90 
17. Bullone M, Pouyet M, Lavoie JP. Age associated changes in peripheral airway smooth 
muscle mass of healthy horses. Vet J. 2017;226:62-4. 
18. Leclere M, Bedard C, Cortes-Dubly ML, Lavoie JP. Blood hypercoagulability and 
systemic inflammation in horses with heaves. Vet J. 2015;206(1):105-7. 
19. Lavoie-Lamoureux A, Leclere M, Lemos K, Wagner B, Lavoie JP. Markers of systemic 
inflammation in horses with heaves. J Vet Intern Med. 2012;26(6):1419-26. 
20. Leclere M, Lavoie-Lamoureux A, Gélinas-Lymburner É, David F, Martin JG, Lavoie J-
P. Effect of Antigenic Exposure on Airway Smooth Muscle Remodeling in an Equine Model of 
Chronic Asthma. American Journal of Respiratory Cell and Molecular Biology. 
2011;45(1):181-7. 
21. Bullone M, Lavoie JP. Asthma "of horses and men"--how can equine heaves help us 
better understand human asthma immunopathology and its functional consequences? Mol 
Immunol. 2015;66(1):97-105. 
22. Bullone M, Beauchamp G, Godbout M, Martin JG, Lavoie JP. Endobronchial 
Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an Equine Asthma 
Model. PLoS One. 2015;10(9):e0136284. 
23. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the 
diagnosis, management, and prevention of chronic obstructive pulmonary disease. 
NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop 
summary. American journal of respiratory and critical care medicine. 2001;163(5):1256-76. 
24. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: 
a summary of the ATS/ERS position paper. The European respiratory journal. 2004;23(6):932-
46. 
25. Chronic obstructive pulmonary disease. National clinical guideline on management of 
chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59 
Suppl 1:1-232. 
26. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and 
inflammation. Nature reviews Immunology. 2013;13(3):159-75. 
27. Maton A. Human biology and health. Englewood Cliffs, N.J.: Prentice Hall; 1997. 
28. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. 
Neutrophils: molecules, functions and pathophysiological aspects. Laboratory investigation; a 
journal of technical methods and pathology. 2000;80(5):617-53. 
29. Nathan C. Neutrophils and immunity: challenges and opportunities. Nature reviews 
Immunology. 2006;6(3):173-82. 
30. Razin E, Cordon-Cardo C, Good RA. Growth of a pure population of mouse mast cells 
in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. 
Proceedings of the National Academy of Sciences of the United States of America. 
1981;78(4):2559-61. 
31. Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the 
secretory pathways involved. Frontiers in immunology. 2014;5:569. 
32. Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. 
Gut. 2016;65(1):155-68. 
33. Prussin C, Metcalfe DD. 4. IgE, mast cells, basophils, and eosinophils. J Allergy Clin 
Immunol. 2003;111(2 Suppl):S486-94. 
 
91 
34. Jacobs L, Nawrot TS, de Geus B, Meeusen R, Degraeuwe B, Bernard A, et al. Subclinical 
responses in healthy cyclists briefly exposed to traffic-related air pollution: an intervention 
study. Environmental health : a global access science source. 2010;9:64. 
35. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clinical cancer research : an 
official journal of the American Association for Cancer Research. 2008;14(21):6735-41. 
36. De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the 
metastatic phenotype of tumors releasing interleukin-8. Clinical cancer research : an official 
journal of the American Association for Cancer Research. 2004;10(15):4895-900. 
37. Mauer AM, Athens JW, Ashenbrucker H, Cartwright GE, Wintrobe MM. Leukokinetic 
Studies. Ii. A Method for Labeling Granulocytes in Vitro with Radioactive 
Diisopropylfluorophosphate (Dfp). J Clin Invest. 1960;39(9):1481-6. 
38. Basu S, Hodgson G, Katz M, Dunn AR. Evaluation of role of G-CSF in the production, 
survival, and release of neutrophils from bone marrow into circulation. Blood. 2002;100(3):854-
61. 
39. Carakostas MC, Moore WE, Smith JE. Intravascular neutrophilic granulocyte kinetics 
in horses. Am J Vet Res. 1981;42(4):623-5. 
40. Stevens A, Lowe JS, Young B. Wheater's basic histopathology : a colour atlas and text. 
4th ed. / [edited] by Alan Stevens, James S. Lowe, Barbara Young 
drawings by Philip J. Deakin.. ed. Edinburgh 
Toronto: Edinburgh 
Toronto : Churchill Livingstone; 2002. 
41. Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN, et al. Selective roles 
for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. 
J Immunol. 2003;170(10):5268-75. 
42. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte 
survival and programmed cell death by cytokines and bacterial products. Blood. 
1992;80(8):2012-20. 
43. Altznauer F, Martinelli S, Yousefi S, Thurig C, Schmid I, Conway EM, et al. 
Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally 
differentiated neutrophils. J Exp Med. 2004;199(10):1343-54. 
44. Lawrence SM, Corriden R, Nizet V. The Ontogeny of a Neutrophil: Mechanisms of 
Granulopoiesis and Homeostasis. Microbiol Mol Biol Rev. 2018;82(1). 
45. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. 
Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host 
defense against Candida albicans. PLoS pathogens. 2009;5(10):e1000639. 
46. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. 
Neutrophil Extracellular Traps Kill Bacteria. Science. 2004;303(5663):1532-5. 
47. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. 
Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a 
predominant role of histones. PLoS One. 2012;7(2):e32366. 
48. Monteseirin J. Neutrophils and asthma. J Investig Allergol Clin Immunol. 
2009;19(5):340-54. 
49. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-α in the 
sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor 
expression, and chemotaxis. European Journal of Immunology. 2002;32(2):393-403. 
 
92 
50. Macdowell AL, Peters SP. Neutrophils in asthma. Curr Allergy Asthma Rep. 
2007;7(6):464-8. 
51. Lavinskiene S, Bajoriuniene I, Malakauskas K, Jeroch J, Sakalauskas R. Sputum 
neutrophil count after bronchial allergen challenge is related to peripheral blood neutrophil 
chemotaxis in asthma patients. Inflamm Res. 2014;63(11):951-9. 
52. Zhang Y, Lin J, Su N, Liu G, Nong Y, Zhang X, et al. [Airway inflammatory phenotypes 
of asthmatic patients]. Zhonghua Jie He He Hu Xi Za Zhi. 2015;38(5):348-51. 
53. Gounni AS, Lamkhioued B, Koussih L, Ra C, Renzi PM, Hamid Q. Human neutrophils 
express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB 
J. 2001;15(6):940-9. 
54. Alphonse MP, Saffar AS, Shan L, HayGlass KT, Simons FE, Gounni AS. Regulation of 
the high affinity IgE receptor (Fc epsilonRI) in human neutrophils: role of seasonal allergen 
exposure and Th-2 cytokines. PLoS One. 2008;3(4):e1921. 
55. Herteman N, Vargas A, Lavoie JP. Characterization of Circulating Low-Density 
Neutrophils Intrinsic Properties in Healthy and Asthmatic Horses. Sci Rep. 2017;7(1):7743. 
56. Yoo SK, Starnes TW, Deng Q, Huttenlocher A. Lyn is a redox sensor that mediates 
leukocyte wound attraction in vivo. Nature. 2011;480(7375):109-12. 
57. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-
cytochrome component of the human neutrophil microbicidal oxidase: translocation during 
activation. J Cell Biol. 1983;97(1):52-61. 
58. Hager M, Cowland JB, Borregaard N. Neutrophil granules in health and disease. J Intern 
Med. 2010;268(1):25-34. 
59. Kruger P, Saffarzadeh M, Weber ANR, Rieber N, Radsak M, von Bernuth H, et al. 
Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury. PLoS pathogens. 
2015;11(3):e1004651. 
60. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of 
pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. 
Cell Metab. 2006;3(3):177-85. 
61. Lavoie-Lamoureux A, Moran K, Beauchamp G, Mauel S, Steinbach F, Lefebvre-Lavoie 
J, et al. IL-4 activates equine neutrophils and induces a mixed inflammatory cytokine expression 
profile with enhanced neutrophil chemotactic mediator release ex vivo. Am J Physiol Lung Cell 
Mol Physiol. 2010;299(4):L472-82. 
62. Joubert P, Cordeau ME, Boyer A, Silversides DW, Lavoie JP. Cytokine expression by 
peripheral blood neutrophils from heaves-affected horses before and after allergen challenge. 
Vet J. 2008;178(2):227-32. 
63. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. 
Immunol Today. 1995;16(1):21-6. 
64. Tamassia N, Bianchetto-Aguilera F, Arruda-Silva F, Gardiman E, Gasperini S, Calzetti 
F, et al. Cytokine production by human neutrophils: Revisiting the “dark side of the moon”. 
European Journal of Clinical Investigation. 2018;48(S2):e12952. 
65. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, 
detection and consequences in general practice. The European respiratory journal. 
2008;31(2):320-5. 




67. Rodrigo GJ, Plaza V. Body mass index and response to emergency department treatment 
in adults with severe asthma exacerbations: a prospective cohort study. Chest. 
2007;132(5):1513-9. 
68. Garcia-Martin E, Garcia-Menaya J, Sanchez B, Martinez C, Rosendo R, Agundez JA. 
Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and 
allergic rhinitis. Clin Exp Allergy. 2007;37(8):1175-82. 
69. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. 
Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. 
American journal of respiratory and critical care medicine. 2003;168(11):1308-11. 
70. Cerveri I, Cazzoletti L, Corsico AG, Marcon A, Niniano R, Grosso A, et al. The impact 
of cigarette smoking on asthma: a population-based international cohort study. Int Arch Allergy 
Immunol. 2012;158(2):175-83. 
71. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled 
corticosteroids in the management of recurrent and/or chronic asthma in adults and children. 
Cochrane Database Syst Rev. 2012(5):CD002314. 
72. Reddel HK, FitzGerald JM, Bateman ED, Bacharier LB, Becker A, Brusselle G, et al. 
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-
acting bronchodilators alone is no longer recommended for adults and adolescents. The 
European respiratory journal. 2019;53(6). 
73. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect 
of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir 
Dis. 1992;145(3):669-74. 
74. Meijer RJ, Kerstjens HA, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of 
inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients 
with asthma. Thorax. 1999;54(10):894-9. 
75. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled 
budesonide on markers of airway inflammation in patients with mild asthma. Thorax. 
1999;54(2):108-14. 
76. Covar RA. Pivotal efficacy trials of inhaled corticosteroids in asthma. Ann Allergy 
Asthma Immunol. 2016;117(6):582-8. 
77. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled 
corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly 
diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin 
Immunol. 1992;90(1):32-42. 
78. Erjefalt JS, Erjefalt I, Sundler F, Persson CG. In vivo restitution of airway epithelium. 
Cell Tissue Res. 1995;281(2):305-16. 
79. Dorscheid DR, Wojcik KR, Sun S, Marroquin B, White SR. Apoptosis of airway 
epithelial cells induced by corticosteroids. American journal of respiratory and critical care 
medicine. 2001;164(10 Pt 1):1939-47. 
80. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet 
TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nature 
Medicine. 2007;13:463. 
81. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 




82. Beck IM, Vanden Berghe W, Vermeulen L, Yamamoto KR, Haegeman G, De Bosscher 
K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and 
kinases and phosphatases. Endocr Rev. 2009;30(7):830-82. 
83. Kagoshima M, Wilcke T, Ito K, Tsaprouni L, Barnes PJ, Punchard N, et al. 
Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA 
methylation. Eur J Pharmacol. 2001;429(1-3):327-34. 
84. Islam KN, Mendelson CR. Glucocorticoid/glucocorticoid receptor inhibition of 
surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive 
changes in histone modification at the SP-A promoter. Mol Endocrinol. 2008;22(3):585-96. 
85. Geng CD, Pedersen KB, Nunez BS, Vedeckis WV. Human glucocorticoid receptor alpha 
transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific 
functions. Biochemistry. 2005;44(20):7395-405. 
86. Reichardt HM, Tuckermann JP, Gottlicher M, Vujic M, Weih F, Angel P, et al. 
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid 
receptor. EMBO J. 2001;20(24):7168-73. 
87. Huo Y, Rangarajan P, Ling E-A, Dheen ST. Dexamethasone inhibits the Nox-dependent 
ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. 
BMC Neuroscience. 2011;12(1):49. 
88. Herbert WJ. Veterinary immunology. Oxford: Oxford, Blackwell Scientific 
Publications; 1970. 
89. Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid 
sensitivity and resistance. Mol Cell Endocrinol. 2009;300(1-2):7-16. 
90. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone 
deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB 
suppression. J Exp Med. 2006;203(1):7-13. 
91. Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human 
glucocorticoid receptor: molecular basis of biologic function. Steroids. 2010;75(1):1-12. 
92. Barnes PJ. Reduced histone deacetylase in COPD: clinical implications. Chest. 
2006;129(1):151-5. 
93. Barnes PJ. Asthma and COPD : basic mechanisms and clinical management. Kidlington: 
Academic Press; 2009. 
94. Tizard IR. Veterinary immunology. St. Louis, Mo.: Elsevier/Saunders; 2013. 
95. Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. The 
allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett. 
2007;113(1):6-18. 
96. Thomson NC, Spears M. The influence of smoking on the treatment response in patients 
with asthma. Curr Opin Allergy Clin Immunol. 2005;5(1):57-63. 
97. Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER. Advances in 
neutrophil biology: clinical implications. Chest. 2008;134(3):606-12. 
98. Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection 
and disease. Seminars in immunopathology. 2013;35(4):513-30. 
99. Lavoie JP, Maghni K, Desnoyers M, Taha R, Martin JG, Hamid QA. Neutrophilic airway 
inflammation in horses with heaves is characterized by a Th2-type cytokine profile. American 
journal of respiratory and critical care medicine. 2001;164(8 Pt 1):1410-3. 
 
95 
100. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone 
deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 
2005;352(19):1967-76. 
101. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, et al. Relative 
corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. American 
journal of respiratory and critical care medicine. 2006;174(2):134-41. 
102. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM. p38 Mitogen-
activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: 
role in steroid-insensitive asthma. J Allergy Clin Immunol. 2002;109(4):649-57. 
103. Matthews JG, Ito K, Barnes PJ, Adcock IM. Defective glucocorticoid receptor nuclear 
translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J 
Allergy Clin Immunol. 2004;113(6):1100-8. 
104. Pujols L, Mullol J, Picado C. Alpha and beta glucocorticoid receptors: relevance in 
airway diseases. Curr Allergy Asthma Rep. 2007;7(2):93-9. 
105. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, et al. Hypoxia-
induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp 
Med. 2005;201(1):105-15. 
106. Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, et al. 
Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen 
depletion to influence resolution of inflammation. Immunity. 2014;40(1):66-77. 
107. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and 
cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603-16. 
108. Chiva M, Guarner C, Peralta C, Llovet T, Gomez G, Soriano G, et al. Intestinal mucosal 
oxidative damage and bacterial translocation in cirrhotic rats. Eur J Gastroenterol Hepatol. 
2003;15(2):145-50. 
109. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, et al. 
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in 
mice. J Clin Invest. 2004;114(9):1248-59. 
110. Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith CA. Frequency of glutathione S-
transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol. 
1997;16(7):356-60. 
111. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter 
polymorphisms in human disease. Free Radic Biol Med. 2004;37(8):1097-104. 
112. Paul B, Sbarra AJ. The role of the phagocyte in host-parasite interactions. 13. The direct 
quantitative estimation of H2O2 in phagocytizing cells. Biochim Biophys Acta. 
1968;156(1):168-78. 
113. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production 
by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest. 1973;52(3):741-4. 
114. Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. 
Thorax. 1998;53(7):601-12. 
115. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air 
of asthmatics. The European respiratory journal. 1993;6(9):1368-70. 
116. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric 
oxide in chronic obstructive pulmonary disease. American journal of respiratory and critical 
care medicine. 1998;157(3 Pt 1):998-1002. 
117. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol. 2003;15(2):247-54. 
 
96 
118. Hatch GE. Asthma, inhaled oxidants, and dietary antioxidants. Am J Clin Nutr. 
1995;61(3 Suppl):625S-30S. 
119. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath 
condensate of patients with asthma. American journal of respiratory and critical care medicine. 
2000;162(4 Pt 1):1273-6. 
120. Kaminsky DA, Mitchell J, Carroll N, James A, Soultanakis R, Janssen Y. Nitrotyrosine 
formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol. 
1999;104(4 Pt 1):747-54. 
121. Yoshikawa S, Kayes SG, Parker JC. Eosinophils increase lung microvascular 
permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and 
vasoconstriction unaffected by eosinophil peroxidase inhibition. Am Rev Respir Dis. 
1993;147(4):914-20. 
122. Zhang P, Wang YZ, Kagan E, Bonner JC. Peroxynitrite targets the epidermal growth 
factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem. 
2000;275(29):22479-86. 
123. Groves JT. Peroxynitrite: reactive, invasive and enigmatic. Curr Opin Chem Biol. 
1999;3(2):226-35. 
124. Cannady SB, Batra PS, Leahy R, Citardi MJ, Janocha A, Ricci K, et al. Signal 
transduction and oxidative processes in sinonasal polyposis. J Allergy Clin Immunol. 
2007;120(6):1346-53. 
125. Xu W, Zheng S, Dweik RA, Erzurum SC. Role of epithelial nitric oxide in airway viral 
infection. Free Radic Biol Med. 2006;41(1):19-28. 
126. Guo FH, Comhair SA, Zheng S, Dweik RA, Eissa NT, Thomassen MJ, et al. Molecular 
mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-
translational regulation of NO synthesis. J Immunol. 2000;164(11):5970-80. 
127. Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic 
markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. 
Thorax. 2018;73(12):1110-9. 
128. Sensors, Transmitters, and Targets in Mitochondrial Oxygen Shortage—A Hypoxia-
Inducible Factor Relay Story. Antioxidants & Redox Signaling. 2014;20(2):339-52. 
129. Hernansanz-Agustín P, Izquierdo-Álvarez A, Sánchez-Gómez FJ, Ramos E, Villa-Piña 
T, Lamas S, et al. Acute hypoxia produces a superoxide burst in cells. Free Radical Biology and 
Medicine. 2014;71:146-56. 
130. Brown DM, Drost E, Donaldson K, MacNee W. Deformability and CD11/CD18 
expression of sequestered neutrophils in normal and inflamed lungs. Am J Respir Cell Mol Biol. 
1995;13(5):531-9. 
131. Staudt LM. Oncogenic activation of NF-kappaB. Cold Spring Harb Perspect Biol. 
2010;2(6):a000109. 
132. Eiserich JP, Vossen V, O'Neill CA, Halliwell B, Cross CE, van der Vliet A. Molecular 
mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette 
smoke. FEBS Lett. 1994;353(1):53-6. 
133. Spencer JP, Jenner A, Chimel K, Aruoma OI, Cross CE, Wu R, et al. DNA damage in 
human respiratory tract epithelial cells: damage by gas phase cigarette smoke apparently 




134. Dinkova-Kostova AT, Holtzclaw WD, Kensler TW. The role of Keap1 in cellular 
protective responses. Chem Res Toxicol. 2005;18(12):1779-91. 
135. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal 
ageing: causal or correlative? Nucleic Acids Res. 2007;35(22):7417-28. 
136. Wnuk M, Bugno-Poniewierska M, Lewinska A, Oklejewicz B, Zabek T, Bartosz G, et 
al. Age-related changes in genomic stability of horses. Mech Ageing Dev. 2011;132(5):257-68. 
137. Kirschvink N, Art T, Lekeux P, Roberts C, Gustin P. Effects of 8-epi-PGF2alpha on 
isolated bronchial smooth muscle of healthy and heaves-affected horses. J Vet Pharmacol Ther. 
2001;24(3):215-21. 
138. Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol. 2013;4:263. 
139. Kirschvink N, de Moffarts B, Lekeux P. The oxidant/antioxidant equilibrium in horses. 
Vet J. 2008;177(2):178-91. 
140. Boe DM, Boule LA, Kovacs EJ. Innate immune responses in the ageing lung. Clin Exp 
Immunol. 2017;187(1):16-25. 
141. Park HS, Kim SR, Lee YC. Impact of oxidative stress on lung diseases. Respirology. 
2009;14(1):27-38. 
142. Art T, Kirschvink N, Smith N, Lekeux P. Indices of oxidative stress in blood and 
pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Equine 
Vet J. 1999;31(5):397-401. 
143. Deaton CM, Marlin DJ, Smith NC, Harris PA, Roberts CA, Schroter RC, et al. 
Pulmonary epithelial lining fluid and plasma ascorbic acid concentrations in horses affected by 
recurrent airway obstruction. Am J Vet Res. 2004;65(1):80-7. 
144. Cannizzo ES, Clement CC, Sahu R, Follo C, Santambrogio L. Oxidative stress, inflamm-
aging and immunosenescence. J Proteomics. 2011;74(11):2313-23. 
145. Davalli P, Mitic T, Caporali A, Lauriola A, D'Arca D. ROS, Cell Senescence, and Novel 
Molecular Mechanisms in Aging and Age-Related Diseases. Oxid Med Cell Longev. 
2016;2016:3565127. 
146. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. 
J Biol Chem. 1995;270(3):1230-7. 
147. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of 
HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl 
hydroxylation. Science. 2001;292(5516):468-72. 
148. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for 
VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 
2001;292(5516):464-8. 
149. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C. 
elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by 
prolyl hydroxylation. Cell. 2001;107(1):43-54. 
150. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-
loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National 
Academy of Sciences of the United States of America. 1995;92(12):5510-4. 
151. Bracken CP, Whitelaw ML, Peet DJ. The hypoxia-inducible factors: key transcriptional 
regulators of hypoxic responses. Cell Mol Life Sci. 2003;60(7):1376-93. 




153. Prabhakar NR, Semenza GL. Oxygen Sensing and Homeostasis. Physiology (Bethesda). 
2015;30(5):340-8. 
154. Bull TM, Clark B, McFann K, Moss M, National Institutes of Health/National Heart L, 
Blood Institute AN. Pulmonary vascular dysfunction is associated with poor outcomes in 
patients with acute lung injury. American journal of respiratory and critical care medicine. 
2010;182(9):1123-8. 
155. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, 
et al. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased 
in asthma and rhinitis. Allergy. 2011;66(7):909-18. 
156. Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in 
chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transplant. 
2012;31(6):557-64. 
157. Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-
inducible factor 1. Biochem J. 2007;405(1):1-9. 
158. Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, et al. 
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive 
endothelial cells. Am J Pathol. 2010;176(3):1130-8. 
159. Tonnel AB, Gosset P, Tillie-Leblond I. Characteristics of the Inflammatory response in 
bronchial lavage fluids from patients with status asthmaticus. Int Arch Allergy Immunol. 
2001;124(1-3):267-71. 
160. Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in 
fatal attacks of asthma. The European respiratory journal. 1996;9(4):709-15. 
161. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl. 
2001;34:50s-9s. 
162. Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL, Jr., Reichner JS. HIF-
1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-
alpha. Am J Physiol Cell Physiol. 2001;281(6):C1971-7. 
163. Scharte M, Han X, Bertges DJ, Fink MP, Delude RL. Cytokines induce HIF-1 DNA 
binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol 
Gastrointest Liver Physiol. 2003;284(3):G373-84. 
164. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-
1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between 
inflammation and oncogenesis. FASEB J. 2003;17(14):2115-7. 
165. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, et al. HIF-
1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645-57. 
166. Barnes PJ. Biochemical basis of asthma therapy. J Biol Chem. 2011;286(38):32899-905. 
167. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking 
and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest. 
2006;129(3):661-8. 
168. McGuinness AJ, Sapey E. Oxidative Stress in COPD: Sources, Markers, and Potential 
Mechanisms. J Clin Med. 2017;6(2). 
169. Paone G, Conti V, Vestri A, Leone A, Puglisi G, Benassi F, et al. Analysis of sputum 
markers in the evaluation of lung inflammation and functional impairment in symptomatic 
smokers and COPD patients. Dis Markers. 2011;31(2):91-100. 
 
99 
170. Kelly VJ, Hibbert KA, Kohli P, Kone M, Greenblatt EE, Venegas JG, et al. Hypoxic 
Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in 
Asthma. American journal of respiratory and critical care medicine. 2017;196(7):834-44. 
171. Esteban-Gorgojo I, Antolín-Amérigo D, Domínguez-Ortega J, Quirce S. Non-
eosinophilic asthma: current perspectives. J Asthma Allergy. 2018;11:267-81. 
172. An TJ, Rhee CK, Kim JH, Lee YR, Chon JY, Park CK, et al. Effects of Macrolide and 
Corticosteroid in Neutrophilic Asthma Mouse Model. Tuberc Respir Dis (Seoul). 
2018;81(1):80-7. 
173. Fitzpatrick AM, Higgins M, Holguin F, Brown LA, Teague WG, National Institutes of 
Health/National Heart L, et al. The molecular phenotype of severe asthma in children. J Allergy 
Clin Immunol. 2010;125(4):851-7 e18. 
174. Brasier AR, Victor S, Boetticher G, Ju H, Lee C, Bleecker ER, et al. Molecular 
phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived 
cytokines. J Allergy Clin Immunol. 2008;121(1):30-7 e6. 
175. Giguere S, Viel L, Lee E, MacKay RJ, Hernandez J, Franchini M. Cytokine induction in 
pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone 
propionate. Vet Immunol Immunopathol. 2002;85(3-4):147-58. 
176. Padoan E, Ferraresso S, Pegolo S, Castagnaro M, Barnini C, Bargelloni L. Real time 
RT-PCR analysis of inflammatory mediator expression in recurrent airway obstruction-affected 
horses. Vet Immunol Immunopathol. 2013;156(3-4):190-9. 
177. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, et al. Relative 
corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe 
asthma. Thorax. 2008;63(9):784-90. 
178. Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG. Increased 
elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-
8. Am J Physiol Lung Cell Mol Physiol. 2000;278(1):L33-41. 
179. Tian BP, Xia LX, Bao ZQ, Zhang H, Xu ZW, Mao YY, et al. Bcl-2 inhibitors reduce 
steroid-insensitive airway inflammation. J Allergy Clin Immunol. 2017;140(2):418-30. 
180. Robins S, Roussel L, Schachter A, Risse PA, Mogas AK, Olivenstein R, et al. Steroid-
insensitive ERK1/2 activity drives CXCL8 synthesis and neutrophilia by airway smooth muscle. 
Am J Respir Cell Mol Biol. 2011;45(5):984-90. 
181. Hamilton LM, Torres-Lozano C, Puddicombe SM, Richter A, Kimber I, Dearman RJ, et 
al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in 
severe asthma. Clin Exp Allergy. 2003;33(2):233-40. 
182. Kobayashi Y, Bossley C, Gupta A, Akashi K, Tsartsali L, Mercado N, et al. Passive 
smoking impairs histone deacetylase-2 in children with severe asthma. Chest. 2014;145(2):305-
12. 
183. Berndt A, Derksen FJ, Venta PJ, Ewart S, Yuzbasiyan-Gurkan V, Robinson NE. 
Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with 
airway inflammation in horses with recurrent airway obstruction. Am J Physiol Lung Cell Mol 
Physiol. 2007;292(4):L936-43. 
184. Lecoq L, Vincent P, Lavoie-Lamoureux A, Lavoie JP. Genomic and non-genomic 




185. Joubert P, Silversides DW, Lavoie JP. Equine neutrophils express mRNA for tumour 
necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, macrophage-inflammatory-protein-2 
but not for IL-4, IL-5 and interferon-gamma. Equine Vet J. 2001;33(7):730-3. 
186. Riihimaki M, Raine A, Art T, Lekeux P, Couetil L, Pringle J. Partial divergence of 
cytokine mRNA expression in bronchial tissues compared to bronchoalveolar lavage cells in 
horses with recurrent airway obstruction. Vet Immunol Immunopathol. 2008;122(3-4):256-64. 
187. Vargas A, Boivin R, Cano P, Murcia Y, Bazin I, Lavoie JP. Neutrophil extracellular 
traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma. Respir 
Res. 2017;18(1):207. 
188. Brightling CE, Green RH, Pavord ID. Biomarkers predicting response to corticosteroid 
therapy in asthma. Treat Respir Med. 2005;4(5):309-16. 
189. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic 
inflammation in severe persistent asthma. American journal of respiratory and critical care 
medicine. 1999;160(5 Pt 1):1532-9. 
190. Holguin F. Oxidative Stress in Airway Diseases. Annals of the American Thoracic 
Society. 2013;10(Supplement):S150-S7. 
191. Niedzwiedz A, Jaworski Z. Oxidant-Antioxidant Status in the Blood of Horses with 
Symptomatic Recurrent Airway Obstruction (RAO). Journal of Veterinary Internal Medicine. 
2014;28(6):1845-52. 
192. Deaton CM. The role of oxidative stress in an equine model of human asthma. Redox 
report : communications in free radical research. 2006;11(2):46-52. 
193. Murcia RY, Vargas A, Lavoie JP. The Interleukin-17 Induced Activation and Increased 
Survival of Equine Neutrophils Is Insensitive to Glucocorticoids. PLoS One. 
2016;11(5):e0154755. 
194. Look DC, Stoll LL, Romig SA, Humlicek A, Britigan BE, Denning GM. Pyocyanin and 
its precursor phenazine-1-carboxylic acid increase IL-8 and intercellular adhesion molecule-1 
expression in human airway epithelial cells by oxidant-dependent mechanisms. J Immunol. 
2005;175(6):4017-23. 
195. Roussel L, LaFayette S, Nguyen D, Baglole CJ, Rousseau S. Differential Contribution 
of the Aryl-Hydrocarbon Receptor and Toll-Like Receptor Pathways to IL-8 Expression in 
Normal and Cystic Fibrosis Airway Epithelial Cells Exposed to Pseudomonas aeruginosa. Front 
Cell Dev Biol. 2016;4:148. 
196. Rada B, Jendrysik MA, Pang L, Hayes CP, Yoo DG, Park JJ, et al. Pyocyanin-enhanced 
neutrophil extracellular trap formation requires the NADPH oxidase. PLoS One. 
2013;8(1):e54205. 
197. Côté O, Clark ME, Viel L, Labbé G, Seah SYK, Khan MA, et al. Secretoglobin 1A1 and 
1A1A Differentially Regulate Neutrophil Reactive Oxygen Species Production, Phagocytosis 
and Extracellular Trap Formation. PLOS ONE. 2014;9(4):e96217. 
198. Chrysanthopoulou A, Mitroulis I, Apostolidou E, Arelaki S, Mikroulis D, Konstantinidis 
T, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J 
Pathol. 2014;233(3):294-307. 
199. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, et al. Excessive neutrophils 
and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am 
J Pathol. 2011;179(1):199-210. 
 
101 
200. Anand RJ, Gribar SC, Li J, Kohler JW, Branca MF, Dubowski T, et al. Hypoxia causes 
an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. Journal of 
leukocyte biology. 2007;82(5):1257-65. 
201. Vollger L, Akong-Moore K, Cox L, Goldmann O, Wang Y, Schafer ST, et al. Iron-
chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) 
in human blood-derived neutrophils. Biosci Rep. 2016;36(3). 
202. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. 
J Allergy Clin Immunol. 2007;120(2):247-54. 
203. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nature reviews 
Immunology. 2009;9(8):556-67. 
204. Ramirez-Velazquez C, Castillo EC, Guido-Bayardo L, Ortiz-Navarrete V. IL-17-
producing peripheral blood CD177+ neutrophils increase in allergic asthmatic subjects. Allergy 
Asthma Clin Immunol. 2013;9(1):23. 
205. DeForge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-
stimulated human whole blood. Biochem Biophys Res Commun. 1991;174(1):18-24. 
206. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) 
inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. 
Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production 
of IL-8 triggered by lipopolysaccharide. J Exp Med. 1993;178(6):2207-11. 
207. Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by 
lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: 
IL-15 as a possible trigger. J Immunol. 2003;170(4):2106-12. 
208. Ainsworth DM, Wagner B, Franchini M, Grunig G, Erb HN, Tan JY. Time-dependent 
alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with 
recurrent airway obstruction. Am J Vet Res. 2006;67(4):669-77. 
209. Nanzer AM, Chambers ES, Ryanna K, Richards DF, Black C, Timms PM, et al. 
Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-
dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol. 
2013;132(2):297-304 e3. 
210. Zijlstra GJ, Ten Hacken NH, Hoffmann RF, van Oosterhout AJ, Heijink IH. Interleukin-
17A induces glucocorticoid insensitivity in human bronchial epithelial cells. The European 
respiratory journal. 2012;39(2):439-45. 
211. Cao J, Ren G, Gong Y, Dong S, Yin Y, Zhang L. Bronchial epithelial cells release IL-6, 
CXCL1 and CXCL8 upon mast cell interaction. Cytokine. 2011;56(3):823-31. 
212. Li TJ, Zhao LL, Qiu J, Zhang HY, Bai GX, Chen L. Interleukin-17 antagonist attenuates 
lung inflammation through inhibition of the ERK1/2 and NF-kappaB pathway in LPS-induced 
acute lung injury. Mol Med Rep. 2017;16(2):2225-32. 
213. Debrue M, Hamilton E, Joubert P, Lajoie-Kadoch S, Lavoie JP. Chronic exacerbation of 
equine heaves is associated with an increased expression of interleukin-17 mRNA in 
bronchoalveolar lavage cells. Vet Immunol Immunopathol. 2005;105(1-2):25-31. 
214. Shabgah AG, Fattahi E, Shahneh FZ. Interleukin-17 in human inflammatory diseases. 
Postepy Dermatol Alergol. 2014;31(4):256-61. 
215. Dong Z, Yuan Y. Accelerated inflammation and oxidative stress induced by LPS in acute 
lung injury: Iotanhibition by ST1926. Int J Mol Med. 2018;41(6):3405-21. 
216. Britigan BE, Roeder TL, Rasmussen GT, Shasby DM, McCormick ML, Cox CD. 
Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin 
 
102 
generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for 
Pseudomonas-associated tissue injury. J Clin Invest. 1992;90(6):2187-96. 
217. Fick RB, Jr. Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest. 
1989;96(1):158-64. 
218. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin 
Microbiol Rev. 1991;4(1):35-51. 
219. Priyaja P, Jayesh P, Philip R, Bright Singh IS. Pyocyanin induced in vitro oxidative 
damage and its toxicity level in human, fish and insect cell lines for its selective biological 
applications. Cytotechnology. 2016;68(1):143-55. 
220. Muller M. Premature cellular senescence induced by pyocyanin, a redox-active 
Pseudomonas aeruginosa toxin. Free Radic Biol Med. 2006;41(11):1670-7. 
221. Li T, Huang X, Yuan Z, Wang L, Chen M, Su F, et al. Pyocyanin induces NK92 cell 
apoptosis via mitochondrial damage and elevated intracellular Ca(2). Innate Immun. 
2019;25(1):3-12. 
222. Rada B, Gardina P, Myers TG, Leto TL. Reactive oxygen species mediate inflammatory 
cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to 
Pseudomonas pyocyanin. Mucosal Immunol. 2011;4(2):158-71. 
223. Prince LR, Bianchi SM, Vaughan KM, Bewley MA, Marriott HM, Walmsley SR, et al. 
Subversion of a lysosomal pathway regulating neutrophil apoptosis by a major bacterial toxin, 
pyocyanin. J Immunol. 2008;180(5):3502-11. 
224. Pan NY, Hui WS, Tipoe GL, Taylor GW, Leung RY, Lam WK, et al. Inhibition of 
pyocyanin-potentiated IL-8 release by steroids in bronchial epithelial cells. Respir Med. 
2006;100(9):1614-22. 
225. Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN, Ho CS, et al. Inhaled fluticasone reduces 
sputum inflammatory indices in severe bronchiectasis. American journal of respiratory and 
critical care medicine. 1998;158(3):723-7. 
226. Newton R, Hart LA, Stevens DA, Bergmann M, Donnelly LE, Adcock IM, et al. Effect 
of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) 
and kappaB-dependent transcription in epithelial cells. Eur J Biochem. 1998;254(1):81-9. 
227. Lavoie JP, Pasloske K, Joubert P, Cordeau ME, Mancini J, Girard Y, et al. Lack of 
clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses. J Vet Intern 
Med. 2006;20(1):175-81. 
228. Lavoie JP, Leguillette R, Pasloske K, Charette L, Sawyer N, Guay D, et al. Comparison 
of effects of dexamethasone and the leukotriene D4 receptor antagonist L-708,738 on lung 
function and airway cytologic findings in horses with recurrent airway obstruction. Am J Vet 
Res. 2002;63(4):579-85. 
229. Li S, Zhang J, Yang H, Wu C, Dang X, Liu Y. Copper depletion inhibits CoCl2-induced 
aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of 
Snail/Twist-mediated epithelial-mesenchymal transition. Sci Rep. 2015;5:12410. 
230. Yuan Y, Hilliard G, Ferguson T, Millhorn DE. Cobalt inhibits the interaction between 
hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-
inducible factor-alpha. J Biol Chem. 2003;278(18):15911-6. 
231. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Summers C, Thompson AAR, et 
al. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus 
in human neutrophils. J Immunol. 2011;186(1):453-63. 
 
103 
232. Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK. A novel role of hypoxia-
inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in 
human endothelial cells. J Immunol. 2006;177(10):7211-24. 
233. Lawrence H, Deehan DJ, Holland JP, Anjum SA, Mawdesley AE, Kirby JA, et al. Cobalt 
ions recruit inflammatory cells in vitro through human Toll-like receptor 4. Biochem Biophys 
Rep. 2016;7:374-8. 
234. Lawrence H, Deehan D, Holland J, Kirby J, Tyson-Capper A. The immunobiology of 
cobalt: demonstration of a potential aetiology for inflammatory pseudotumours after metal-on-
metal replacement of the hip. Bone Joint J. 2014;96-B(9):1172-7. 
235. Branitzki-Heinemann K, Mollerherm H, Vollger L, Husein DM, de Buhr N, Blodkamp 
S, et al. Formation of Neutrophil Extracellular Traps under Low Oxygen Level. Frontiers in 
immunology. 2016;7:518. 
236. Schwartz EA, Zhang WY, Karnik SK, Borwege S, Anand VR, Laine PS, et al. Nutrient 
modification of the innate immune response: a novel mechanism by which saturated fatty acids 
greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol. 2010;30(4):802-8. 
237. Choi DC, Lee JY, Lim EJ, Baik HH, Oh TH, Yune TY. Inhibition of ROS-induced 
p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after 
spinal cord injury in rats. Exp Neurol. 2012;236(2):268-82. 
238. Martin EM, Till RL, Sheats MK, Jones SL. Misoprostol Inhibits Equine Neutrophil 
Adhesion, Migration, and Respiratory Burst in an In Vitro Model of Inflammation. Front Vet 
Sci. 2017;4:159. 
239. Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CRW. Pro-
Inflammatory Effects of Interleukin-17A on Vascular Smooth Muscle Cells Involve NAD(P)H- 
Oxidase Derived Reactive Oxygen Species. Journal of Vascular Research. 2011;48(1):52-8. 
240. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE, Demedts MG, 
Verleden GM. N-acetylcysteine inhibits interleukin-17-induced interleukin-8 production from 
human airway smooth muscle cells: a possible role for anti-oxidative treatment in chronic lung 
rejection? The Journal of Heart and Lung Transplantation. 2004;23(1):122-7. 
241. Williams AE, Jose RJ, Mercer PF, Brealey D, Parekh D, Thickett DR, et al. Evidence 
for chemokine synergy during neutrophil migration in ARDS. Thorax. 2017;72(1):66-73. 
242. Moret I, Lorenzo MJ, Sarria B, Cases E, Morcillo E, Perpina M, et al. Increased lung 
neutrophil apoptosis and inflammation resolution in nonresponding pneumonia. The European 
respiratory journal. 2011;38(5):1158-64. 
243. Schutte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, et al. 
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and 
cardiogenic pulmonary oedema. The European respiratory journal. 1996;9(9):1858-67. 
244. De Alessandris S, Ferguson GJ, Dodd AJ, Juss JK, Devaprasad A, Piper S, et al. 
Neutrophil GM-CSF receptor dynamics in acute lung injury. Journal of leukocyte biology. 
2019;105(6):1183-94. 
245. Zahler S, Kowalski C, Brosig A, Kupatt C, Becker BF, Gerlach E. The function of 
neutrophils isolated by a magnetic antibody cell separation technique is not altered in 
comparison to a density gradient centrifugation method. Journal of immunological methods. 
1997;200(1-2):173-9. 
246. DeForge LE, Tracey DE, Kenney JS, Remick DG. Interleukin-1 receptor antagonist 
protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood. 
































































































	 (Hold)	 	 	 													50°C	-	2	minutes	
	 (Activation	of	the	enzyme)	 95°C	-	10	minutes	




- Using	 the	 RotorGene	 qPCR	 machine,	 choose	 the	 channel	 FAM	 for	 fluorescence	
acquisition	during	the	annealing	/	extension	step	(choose	the	CYB	G	channel).	
*	Change	the	annealing	temperature	based	on	the	primers	has	been	used. 
X   35-45  
